Mocertatug rezetecan (GSK5733584), a B7-H4-targeted antibody-drug conjugate (ADC), in platinum-resistant ovarian cancer (PROC) and endometrial cancer (EC): First results from the global BEHOLD-1 study

  • Oaknin, Ana; 
  • McKean, William; 
  • van Dongen, Marloes; 
  • Ray-Coquard, Isabelle; 
  • Lee, Jung-Yun; 
  • ... Lee, Jeong-Won; 
  • 외 14명
Citations

WEB OF SCIENCE

5
제목
Mocertatug rezetecan (GSK5733584), a B7-H4-targeted antibody-drug conjugate (ADC), in platinum-resistant ovarian cancer (PROC) and endometrial cancer (EC): First results from the global BEHOLD-1 study
저자
Oaknin, Ana; McKean, William; van Dongen, Marloes; Ray-Coquard, Isabelle; Lee, Jung-Yun; Moreno, Victor; Salutari, Vanda; Bedard, Philippe; Boni, Valentina; Miller, Rowan; Lee, Jeong-Won; Lim, Myong Cheol; Frenel, Jean-Sebastien; Shah, Shruti; Carreras, Francisco Jose Gonzalez; Riccio, Antonio; Zildjian, Sybil; Kaisermann, Morrys C.; Veneris, Jennifer; Lheureux, Stephanie
DOI
10.1016/j.ygyno.2026.02.027
발행일
2026-05
유형
Meeting Abstract
저널명
Gynecologic Oncology
권
208
페이지
S454 ~ S455